JP2008512408A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008512408A5 JP2008512408A5 JP2007530616A JP2007530616A JP2008512408A5 JP 2008512408 A5 JP2008512408 A5 JP 2008512408A5 JP 2007530616 A JP2007530616 A JP 2007530616A JP 2007530616 A JP2007530616 A JP 2007530616A JP 2008512408 A5 JP2008512408 A5 JP 2008512408A5
- Authority
- JP
- Japan
- Prior art keywords
- alkylene
- alkyl
- phenyl
- formula
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 20
- 150000001875 compounds Chemical class 0.000 claims 19
- 239000003814 drug Substances 0.000 claims 12
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 9
- 125000003161 (C1-C6) alkylene group Chemical group 0.000 claims 8
- 238000004519 manufacturing process Methods 0.000 claims 8
- 230000002265 prevention Effects 0.000 claims 7
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 6
- 208000035475 disorder Diseases 0.000 claims 6
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 5
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 4
- 208000017170 Lipid metabolism disease Diseases 0.000 claims 3
- 125000000217 alkyl group Chemical group 0.000 claims 3
- 229910052794 bromium Inorganic materials 0.000 claims 3
- 125000004432 carbon atom Chemical group C* 0.000 claims 3
- 229910052801 chlorine Inorganic materials 0.000 claims 3
- 229910052731 fluorine Inorganic materials 0.000 claims 3
- 125000001153 fluoro group Chemical group F* 0.000 claims 3
- 229910052739 hydrogen Inorganic materials 0.000 claims 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 2
- 206010022489 Insulin Resistance Diseases 0.000 claims 2
- 229910004013 NO 2 Inorganic materials 0.000 claims 2
- 206010012601 diabetes mellitus Diseases 0.000 claims 2
- 239000008103 glucose Substances 0.000 claims 2
- 125000001072 heteroaryl group Chemical group 0.000 claims 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 2
- 229910052760 oxygen Inorganic materials 0.000 claims 2
- 229920006395 saturated elastomer Polymers 0.000 claims 2
- 125000001424 substituent group Chemical group 0.000 claims 2
- 229910052717 sulfur Inorganic materials 0.000 claims 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims 2
- 125000001963 4 membered heterocyclic group Chemical group 0.000 claims 1
- 125000002373 5 membered heterocyclic group Chemical group 0.000 claims 1
- 125000004070 6 membered heterocyclic group Chemical group 0.000 claims 1
- 208000032928 Dyslipidaemia Diseases 0.000 claims 1
- 208000001145 Metabolic Syndrome Diseases 0.000 claims 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 claims 1
- 239000013543 active substance Substances 0.000 claims 1
- 230000003178 anti-diabetic effect Effects 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 230000003210 demyelinating effect Effects 0.000 claims 1
- 230000002349 favourable effect Effects 0.000 claims 1
- 125000000623 heterocyclic group Chemical group 0.000 claims 1
- 150000002632 lipids Chemical class 0.000 claims 1
- 208000030159 metabolic disease Diseases 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 208000024891 symptom Diseases 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04021667 | 2004-09-11 | ||
| PCT/EP2005/009269 WO2006029699A1 (en) | 2004-09-11 | 2005-08-27 | 7-azaindoles and their use as ppar agonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008512408A JP2008512408A (ja) | 2008-04-24 |
| JP2008512408A5 true JP2008512408A5 (enExample) | 2008-10-16 |
Family
ID=34926507
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007530616A Abandoned JP2008512408A (ja) | 2004-09-11 | 2005-08-27 | ７−アザインドール類、それらの製造方法及びそれらの医薬としての使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7541464B2 (enExample) |
| EP (1) | EP1794159B1 (enExample) |
| JP (1) | JP2008512408A (enExample) |
| KR (1) | KR20070053243A (enExample) |
| CN (1) | CN101018790A (enExample) |
| AU (1) | AU2005284485A1 (enExample) |
| BR (1) | BRPI0515168A (enExample) |
| CA (1) | CA2580135A1 (enExample) |
| IL (1) | IL181560A0 (enExample) |
| MX (1) | MX2007002689A (enExample) |
| WO (1) | WO2006029699A1 (enExample) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101272784A (zh) | 2005-09-29 | 2008-09-24 | 塞诺菲-安万特股份有限公司 | 苯基-和吡啶基-1,2,4-噁二唑酮衍生物、它们的制备方法和它们作为药物的用途 |
| PE20080188A1 (es) * | 2006-04-18 | 2008-03-10 | Janssen Pharmaceutica Nv | Derivados del acido benzoazepin-oxi-acetico como agonistas de ppar-delta usados para aumentar hdl-c, reducir ldl-c y reducir colesterol |
| RU2009108280A (ru) | 2006-08-08 | 2010-09-20 | Санофи-Авентис (Fr) | Ариламиноарилалкилзамещенные имидазолидин-2,4-дионы, способы их получения, содержащие эти соединения лекарственные средства и их применение |
| EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| DE102007054497B3 (de) | 2007-11-13 | 2009-07-23 | Sanofi-Aventis Deutschland Gmbh | Neue kristalline Diphenylazetidinonhydrate und Verfahren zu deren Herstellung |
| EP2310372B1 (en) | 2008-07-09 | 2012-05-23 | Sanofi | Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof |
| WO2010068601A1 (en) | 2008-12-08 | 2010-06-17 | Sanofi-Aventis | A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof |
| MX2012001729A (es) | 2009-08-26 | 2012-06-13 | Sanofi Sa | Nuevos hidratos cristalinos de fluoroglicosido heteroaromatico, productos farmaceuticos que comprenden estos compuestos, y su empleo. |
| WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
| US8933024B2 (en) | 2010-06-18 | 2015-01-13 | Sanofi | Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases |
| US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
| TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
| TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
| TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
| US8828994B2 (en) | 2011-03-08 | 2014-09-09 | Sanofi | Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
| EP2683699B1 (de) | 2011-03-08 | 2015-06-24 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| US8828995B2 (en) | 2011-03-08 | 2014-09-09 | Sanofi | Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
| US8901114B2 (en) | 2011-03-08 | 2014-12-02 | Sanofi | Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof |
| US8871758B2 (en) | 2011-03-08 | 2014-10-28 | Sanofi | Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof |
| WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| WO2013045413A1 (en) | 2011-09-27 | 2013-04-04 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7119104B2 (en) * | 2001-10-12 | 2006-10-10 | Nippon Chemiphar, Co., Ltd. | Activator of peroxisome proliferator-activated receptor delta |
| PA8594401A1 (es) * | 2003-02-21 | 2004-09-16 | Pfizer | Acidos carboxilicos de heteroarilo condensado como agonista del ppar |
-
2005
- 2005-08-27 CA CA002580135A patent/CA2580135A1/en not_active Abandoned
- 2005-08-27 JP JP2007530616A patent/JP2008512408A/ja not_active Abandoned
- 2005-08-27 CN CNA2005800304627A patent/CN101018790A/zh active Pending
- 2005-08-27 MX MX2007002689A patent/MX2007002689A/es not_active Application Discontinuation
- 2005-08-27 AU AU2005284485A patent/AU2005284485A1/en not_active Abandoned
- 2005-08-27 BR BRPI0515168-6A patent/BRPI0515168A/pt not_active IP Right Cessation
- 2005-08-27 KR KR1020077005673A patent/KR20070053243A/ko not_active Withdrawn
- 2005-08-27 EP EP05778246A patent/EP1794159B1/en not_active Expired - Lifetime
- 2005-08-27 WO PCT/EP2005/009269 patent/WO2006029699A1/en not_active Ceased
-
2007
- 2007-02-26 IL IL181560A patent/IL181560A0/en unknown
- 2007-03-05 US US11/681,923 patent/US7541464B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008512408A5 (enExample) | ||
| JP2006524660A5 (enExample) | ||
| JP2008514655A5 (enExample) | ||
| CY1111310T1 (el) | Ενωσεις για την αγωγη μεταβολικων διαταραχων | |
| SE0104334D0 (sv) | Therapeutic agents | |
| JP2006522035A5 (enExample) | ||
| JP2010530881A5 (enExample) | ||
| JP2008539268A5 (enExample) | ||
| JP2013544276A5 (enExample) | ||
| WO2004073611A3 (en) | Compounds for the treatment of metabolic disorders | |
| JP2002513793A5 (enExample) | ||
| JP2014507477A5 (enExample) | ||
| ATE526018T1 (de) | Verbindungen zur behandlung von stoffwechselstörungen | |
| DE602004024382D1 (de) | Verbindungen zur behandlung von stoffwechselstörungen | |
| MY135954A (en) | Crystalline form of (s)-ethoxy-3-4-(2-4-methanesulfonyloxyphenyl ethoxy) phenyl] propanoic acid | |
| JP2013513607A5 (enExample) | ||
| BRPI0413758A (pt) | compostos para o tratamento de transtornos metabólicos | |
| RU2002101622A (ru) | Нафтохиноновые производные и их использование для лечения и борьбы с туберкулезом | |
| JP2005526773A5 (enExample) | ||
| JP2009509988A5 (enExample) | ||
| UY28896A1 (es) | Formulaciones en polvo para la inhalación , las cuales contienen beta-agonistas enantioméricamente puros | |
| JP2003512494A5 (enExample) | ||
| JP2010510263A5 (enExample) | ||
| JP2008509892A5 (ja) | 高脂血症及び糖尿病の治療のためのｐｐａｒリガンド（ペルオキシソーム増殖剤応答性受容体）として使用されるｎ−（フェニル−オキサゾール−４−イルメトキシメチル）−シクロヘキシル−スクシンアミド誘導体及び関連する化合物 | |
| JP2011006409A5 (enExample) |